US4537738A - Process for orienting partially crystallized 3-hydroxybutyrate polymers - Google Patents

Process for orienting partially crystallized 3-hydroxybutyrate polymers Download PDF

Info

Publication number
US4537738A
US4537738A US06/524,314 US52431483A US4537738A US 4537738 A US4537738 A US 4537738A US 52431483 A US52431483 A US 52431483A US 4537738 A US4537738 A US 4537738A
Authority
US
United States
Prior art keywords
preform
polymer
temperature
drawn
hydroxybutyrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US06/524,314
Inventor
Paul A. Holmes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10532574&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US4537738(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Assigned to IMPERIAL CHEMICAL INDUSTRIES PLC., A CORP. OF GREAT BRITAIN reassignment IMPERIAL CHEMICAL INDUSTRIES PLC., A CORP. OF GREAT BRITAIN ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: HOLMES, PAUL A.
Application granted granted Critical
Publication of US4537738A publication Critical patent/US4537738A/en
Assigned to ZENECA LIMITED reassignment ZENECA LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: IMPERIAL CHEMICAL INDUSTRIES PLC
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/58Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
    • D01F6/62Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters
    • D01F6/625Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters derived from hydroxy-carboxylic acids, e.g. lactones
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2367/00Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
    • C08J2367/04Polyesters derived from hydroxy carboxylic acids, e.g. lactones

Definitions

  • This invention relates to 3-hydroxybutyrate polymers.
  • Poly(3-hydroxybutyrate) is a thermoplastic polyester consisting of repeat units of the formula
  • micro-organisms which is accumulated by many micro-organisms, particularly bacteria, for example of the genera Alcaligenes, Athiorhodium, Azotobacter, Bacillus, Nocardia, Pseudomonas, Rhizobium, and Spirillium, as an energy reserve material.
  • the polymer is conveniently prepared by cultivating the micro-organism in an aqueous medium on a suitable substrate, such as a carbohydrate or methanol, as an energy and carbon source.
  • a suitable substrate such as a carbohydrate or methanol
  • the substrate must, of course, be one that is assimilable by the micro-organism.
  • at least part of the cultivation is preferably conducted under conditions wherein there is a limitation of a nutrient that is essential for growth of the micro-organism but which is not required for polymer accumulation. Examples of suitable processes are described in European Patent Specification Nos. 15669 and 46344.
  • cells containing the polymer can be used as such as a moulding material, for example as described in U.S. Pat. No. 3,107,172, it is generally desirable to separate the polymer from the remainder of the cell material.
  • Methods that have been proposed to effect this separation include breakage of the cells by methods such as treatment with actone, followed by extraction of the polymer from the broken cells by treatment with a solvent in which the polymer is soluble. Examples of such processes are described in U.S. Pat. Nos. 3,036,959 and 3,044,942 in which the solvents employed are pyridine or mixture of methylene and ethanol.
  • Other extraction solvents for the polymer in the form in which it is produced in the cells include cyclic carbonates such as 1,2-propylene carbonate (see U.S. Pat. No. 4,101,533); chloroform (see U.S. Pat. No. 3,275,610); and 1,2-dichloroethane (as disclosed in European Patent Specification No. 15123).
  • U.S. Pat. No. 3,275,610 discloses other methods of cell breakage viz. ultrasonic vibration, grinding, French pressing, freezing/thawing cycles and lysozyme treatment, while as described in the aforementioned European Patent Specification No. 15123, spray or flash drying of the suspension of cells as produced by culturing the micro-organism can also cause sufficient cell breakage to enable the polymer to be extracted from the cells.
  • Copolymers can also be made containing units of other hydroxycarboxylic acids and/or units derived from diols, e.g. ethylene glycol, and/or dicarboxylic acids, e.g. isophthalic acid, by ester interchange occurring when the microbiologically produced polymer or copolymer is melted with such a hydroxycarboxylic acid, lactone thereof, e.g. pivalolactone, diol, dicarboxylic acid and/or polyester produced therefrom.
  • diols e.g. ethylene glycol
  • dicarboxylic acids e.g. isophthalic acid
  • HB polymer we mean not only 3-hydroxybutyrate homopolymer, but also copolymers as described above, provided that the 3-hydroxybutyrate residues from at least 40 mole %, and preferably at least 80 mole %, of the polymer chain.
  • Technique (a) is often adopted for polyesters, e.g. polyethylene terephthalate, and polyamides e.g. poly hexa methylene adipamide (Nylon 66) and polycaprolactam (Nylon 6), whereas technique (b) is often adopted for olefin polymers, e.g. polypropylene and polyethylene.
  • the preform is brittle and can only be drawn to a very small extent before it breaks, i.e. the elongation to break is low.
  • the HB polymer has a degree of crystallinity below that at which it becomes brittle, then the preform can be drawn without breaking but is rubbery and, on release of the drawing force, the product relaxes almost completely. Relaxation can be prevented by effecting further crystallisation of the HB polymer, while maintaining the drawing force, until the HB polymer becomes non-rubbery.
  • the HB polymer has a crystallinity within a certain range at the time of drawing, oriented products can be obtained.
  • the present invention provides a process for the production of an oriented shaped article from an HB polymer comprising uni- or bi-axially drawing a preform of said HB polymer in a partially crystalline state at a temperature between the glass transition temperature, Tg, and the melting point of the HB polymer into said shaped article, and then increasing the degree of crystallinity of the HB polymer by subjecting the drawn preform, while in the drawn condition, to a temperature between the glass transition temperature and the drawing temperature until the drawn article is non-rubbery, the amount of said uni- or bi-axial drawing being such that, after said step of increasing the degree of crystallinity, at least one dimension of the preform has increased by at least 200%, said HB polymer having a degree of crystallinity at the time of drawing, such that the preform is not so brittle that it breaks before achieving said increase in said at least one dimension, and such that the drawn article does not break during the step of increasing the degree of crystallinity.
  • 3-hydroxybutyrate homopolymer has a melting point of about 180° C. and the Tg of the amorphous polymer is about 0° to 5° C.
  • HB copolymers e.g. containing 3-hydroxyvalerate units, have lower melting points than the HB homopolymer and often have a lower Tg.
  • the melting point of the HB copolymer will depend on the proportion of comonomer units: for example a copolymer containing about 25 mole % of 3-hydroxyvalerate units may have a melting point of the order of 130° C.
  • the degree of crystallisation at the time of drawing will generally be above that of the preform leaving the quenching/crystallisation zone. Accordingly the time taken for said transfer and heating (if any) preparatory to drawing should be sufficiently short, and the amount of crystallisation induced in the quenching/crystallisation zone such that the degree of crystallisation at the time of drawing is within the range at which orientation can be induced.
  • the maximum amount of relaxation permitted should be such that, after said drawing and further crystallisation steps, at least one dimension of the preform has been increased by at least 200%.
  • the amount of relaxation permitted during the further crystallisation step is less than 10% of the drawn value (but before any such relaxation) of said at least one dimension that has been increased by at least 200%.
  • the HB polymer was a 3-hydroxybutyrate homo-polymer, hereinafter PHB, produced by aerobic cultivation of Alcaligenes eutrophus mutant S301/C5 (NCIB 11599) on glucose.
  • the PHB was isolated by extraction from the aqueous cell suspension with 1,2-dichloroethane at room temperature followed by separation of the solvent layer, containing the dissolved PHB, from the aqueous layer by decanting.
  • the solution was filtered and then the PHB was precipitated by adding the solution to a methanol/water mixture.
  • the precipitated PHB was separated by filtration, washed with methanol and dried.
  • the dried polymer was formed into a paste with about 10% by weight of chloroform and 1% by weight of finely divided boron nitride was added as a nucleating agent.
  • the paste was granulated by passage through a domestic mincer at room temperature. The granules were then dried in an oven to remove the chloroform and melt extruded at 190° C. and regranulated.
  • the PHB had a weight average molecular weight of 300,000 and a melting point of 176° C.
  • the PHB granules were melt extruded, at a melt temperature of 185° C. at a rate of 0.28 g/min through a die (1) having a circular orifice of diameter 1.585 mm.
  • the molten extrudate (2) was led directly into a bath (3) of water maintained at 60° C. and guided through bath (3) by guides (4, 5).
  • the resultant solidified monofilament (6) was hauled-off at a rate of 0.026 m/sec by a haul-off roller (7) and passed round a pin (8) heated to 120° C. From the pin (8) the monofilament was drawn into a fibre (9) by a second haul-off roller (10).
  • a plate (11) of length 20 cm maintained at 60° C.
  • Heated plate (11) thus provided a heated zone above plate (11) wherein the fibre (9) drawn from pin (8) could be further crystallised. Heated pin (8) served not only to heat the monofilament preform (6) to the drawing temperature, but also to localise the drawing position. The draw ratio was thus the ratio of the circumferential speeds of rollers (10) and (7).
  • the quenching time the length of time (hereinafter termed the quenching time) that the monofilament (6) was in the water bath (3) could be altered: in turn this varied the degree of crystallisation of the monofilament (6) at the time of drawing, i.e. at the time the fibre left pin (8).
  • the total elapsed time from the extrudate (2) leaving die (1) to the fibre leaving pin (8) is hereinafter termed the conditioning time.

Abstract

3-Hydroxybutyrate polymers are formed into oriented shaped articles by drawing a partially crystallized preform to increase at least one dimension by at least 200%, and then increasing the degree of crystallization while maintaining the drawn preform in the drawn condition.

Description

This invention relates to 3-hydroxybutyrate polymers.
Poly(3-hydroxybutyrate) is a thermoplastic polyester consisting of repeat units of the formula
--CH(CH.sub.3).CH.sub.2.CO.O--
which is accumulated by many micro-organisms, particularly bacteria, for example of the genera Alcaligenes, Athiorhodium, Azotobacter, Bacillus, Nocardia, Pseudomonas, Rhizobium, and Spirillium, as an energy reserve material.
The polymer is conveniently prepared by cultivating the micro-organism in an aqueous medium on a suitable substrate, such as a carbohydrate or methanol, as an energy and carbon source. The substrate must, of course, be one that is assimilable by the micro-organism. In order to promote accumulation of the polymer, at least part of the cultivation is preferably conducted under conditions wherein there is a limitation of a nutrient that is essential for growth of the micro-organism but which is not required for polymer accumulation. Examples of suitable processes are described in European Patent Specification Nos. 15669 and 46344.
Polymers containing both 3-hydroxybutyrate units and other hydroxy-carboxylate units, such as 3-hydroxyvalerate units, can also be produced microbiologically. Thus a micro-biologically produced heteropolymer containing 3-hydroxybutyrate and 3-hydroxyvalerate residues is described in Wallen et al in "Environmental Science and Technology" 8 (1974) 576-9. Also, as described in European Patent Specification Nos. 52459 and 69497 various copolymers can be produced by cultivating the micro-organism on certain substrates, such as propionic acid which gives rise to 3-hydroxyvalerate units in the copolymer.
While cells containing the polymer can be used as such as a moulding material, for example as described in U.S. Pat. No. 3,107,172, it is generally desirable to separate the polymer from the remainder of the cell material.
Methods that have been proposed to effect this separation include breakage of the cells by methods such as treatment with actone, followed by extraction of the polymer from the broken cells by treatment with a solvent in which the polymer is soluble. Examples of such processes are described in U.S. Pat. Nos. 3,036,959 and 3,044,942 in which the solvents employed are pyridine or mixture of methylene and ethanol. Other extraction solvents for the polymer in the form in which it is produced in the cells include cyclic carbonates such as 1,2-propylene carbonate (see U.S. Pat. No. 4,101,533); chloroform (see U.S. Pat. No. 3,275,610); and 1,2-dichloroethane (as disclosed in European Patent Specification No. 15123).
U.S. Pat. No. 3,275,610 discloses other methods of cell breakage viz. ultrasonic vibration, grinding, French pressing, freezing/thawing cycles and lysozyme treatment, while as described in the aforementioned European Patent Specification No. 15123, spray or flash drying of the suspension of cells as produced by culturing the micro-organism can also cause sufficient cell breakage to enable the polymer to be extracted from the cells.
Copolymers can also be made containing units of other hydroxycarboxylic acids and/or units derived from diols, e.g. ethylene glycol, and/or dicarboxylic acids, e.g. isophthalic acid, by ester interchange occurring when the microbiologically produced polymer or copolymer is melted with such a hydroxycarboxylic acid, lactone thereof, e.g. pivalolactone, diol, dicarboxylic acid and/or polyester produced therefrom.
In the following description therefore, by the term HB polymer we mean not only 3-hydroxybutyrate homopolymer, but also copolymers as described above, provided that the 3-hydroxybutyrate residues from at least 40 mole %, and preferably at least 80 mole %, of the polymer chain.
In the production of some shaped articles, such as fibres, ribbons, films, and bottles, it is often desired to induce a degree of orientation into the product.
Conventional orientation techniques involve
(a) forming an amorphous preform and then subjecting the preform to tensile stress, e.g. uni- or bi-axially, usually at a temperature above, but near to, the glass transition temperature, Tg, to cause the preform to yield and draw.
(b) drawing a crystalline preform at a temperature below, but near to, the crystalline melting point, Tm.
Technique (a) is often adopted for polyesters, e.g. polyethylene terephthalate, and polyamides e.g. poly hexa methylene adipamide (Nylon 66) and polycaprolactam (Nylon 6), whereas technique (b) is often adopted for olefin polymers, e.g. polypropylene and polyethylene.
We have found that orientation of HB polymers by these techniques is difficult: the conditions for the production of a suitable preform and for drawing are critical and difficult to reproduce consistently. In general the preforms are brittle, even at elevated temperatures, and tend to break before they yield and orient.
We have now found that orientation of an HB polymer preform can be achieved if, at the time of drawing, the HB polymer is in a partially crystallised state.
If, at the time of drawing, the HB polymer is too highly crystallised, then the preform is brittle and can only be drawn to a very small extent before it breaks, i.e. the elongation to break is low. On the other hand, if, at the time of drawing, the HB polymer has a degree of crystallinity below that at which it becomes brittle, then the preform can be drawn without breaking but is rubbery and, on release of the drawing force, the product relaxes almost completely. Relaxation can be prevented by effecting further crystallisation of the HB polymer, while maintaining the drawing force, until the HB polymer becomes non-rubbery. However, we have found that if the degree of crystallinity at the time of drawing is too low, the drawn product breaks during the further crystallising step. Also, if the degree of crystallinity is too low, the polymer tends to be sticky thus creating handling difficulties.
Thus if the HB polymer has a crystallinity within a certain range at the time of drawing, oriented products can be obtained.
Accordingly the present invention provides a process for the production of an oriented shaped article from an HB polymer comprising uni- or bi-axially drawing a preform of said HB polymer in a partially crystalline state at a temperature between the glass transition temperature, Tg, and the melting point of the HB polymer into said shaped article, and then increasing the degree of crystallinity of the HB polymer by subjecting the drawn preform, while in the drawn condition, to a temperature between the glass transition temperature and the drawing temperature until the drawn article is non-rubbery, the amount of said uni- or bi-axial drawing being such that, after said step of increasing the degree of crystallinity, at least one dimension of the preform has increased by at least 200%, said HB polymer having a degree of crystallinity at the time of drawing, such that the preform is not so brittle that it breaks before achieving said increase in said at least one dimension, and such that the drawn article does not break during the step of increasing the degree of crystallinity.
3-hydroxybutyrate homopolymer has a melting point of about 180° C. and the Tg of the amorphous polymer is about 0° to 5° C. HB copolymers, e.g. containing 3-hydroxyvalerate units, have lower melting points than the HB homopolymer and often have a lower Tg. The melting point of the HB copolymer will depend on the proportion of comonomer units: for example a copolymer containing about 25 mole % of 3-hydroxyvalerate units may have a melting point of the order of 130° C.
Since HB polymers crystallise rapidly at temperatures above room temperature, measurement of the precise degree of crystallinity at the time of drawing is not practical on a routine basis. Also the crystallinity range within which orientation can be achieved may vary, depending on the molecular weight of the polymer and/or the nature, proportion, and distribution of any comonomer units in the polymer, and/or on the nature and amount of any nucleating agent added to the polymer, and/or on the drawing conditions, e.g. draw ratio, rate of drawing, drawing temperature.
The appropriate conditions for satisfactory drawing can, however, be determined by simple experimentation.
The preform containing the HB polymer in the requisite crystalline state can conveniently be produced by subjecting an amorphous preform to crystallisation inducing conditions, e.g. heating to, or maintaining at, a temperature between Tg and the melting point, preferably within ±30° C. of the temperature at which the rate of crystallisation is a maximum (for most HB polymers, including HB homopolymer, this is about 70° C.) for a suitable period of time. For example the HB polymer can be melt extruded, through a suitable die, to an amorphous preform which is passed through a quenching/crystallisation zone, e.g. a bath of a suitable liquid, maintained at a temperature below the melting point of the HB polymer so as to solidify the extruded preform and to effect crystallisation. Since, as mentioned hereinbefore, HB polymers crystallise rapidly at room temperature and above, to prevent too much further crystallisation occurring after leaving the quenching/crystallisation zone, the preform is preferably fed directly from said zone to the drawing stage.
In the drawing stage the preform is further heated, if necessary, and subjected to uni- or bi-axial drawing. Preferably the temperature of the preform at the time of drawing is above the temperature of the preform leaving the quenching/crystallisation zone and in particular is between 30° and 80° C. below the melting point of the HB polymer. The degree of draw is such that at least one dimension, i.e. the length in the case of uni-axial drawing or the length and/or breadth in the case of bi-axial drawing, is increased by at least 200%, and preferably by at least 400%.
Since further crystallisation will generally occur while the preform is being transferred from the quenching/crystallisation zone to the drawing stage and during any heating in the drawing stage preparatory to drawing, the degree of crystallisation at the time of drawing will generally be above that of the preform leaving the quenching/crystallisation zone. Accordingly the time taken for said transfer and heating (if any) preparatory to drawing should be sufficiently short, and the amount of crystallisation induced in the quenching/crystallisation zone such that the degree of crystallisation at the time of drawing is within the range at which orientation can be induced.
While the drawn preform is in the drawn condition, e.g. held under tension, further crystallisation is induced, conveniently by passing the drawn preform through a zone maintained at a temperature between Tg and the drawing temperature. Conveniently this further crystallisation zone is maintained at a temperature within ±20° C. of the temperature at which the rate of crystallisation is a maximum. This further crystallisation is conducted until the HB polymer becomes non-rubbery, i.e. so that, on release of the tension, the degree of relaxation is less than 10% of the drawn value of said at least one dimension that has been increased in said drawing stage by at least 200%. Generally the degree of crystallisation of the drawn preform, after said further crystallisation step will be of the order of 70% or more.
In some cases it may be advantageous to permit some relaxation of the drawn preform during passage through the further crystallisation zone. However the maximum amount of relaxation permitted should be such that, after said drawing and further crystallisation steps, at least one dimension of the preform has been increased by at least 200%. Preferably the amount of relaxation permitted during the further crystallisation step is less than 10% of the drawn value (but before any such relaxation) of said at least one dimension that has been increased by at least 200%.
The present invention is further illustrated by the following examples in which the apparatus shown diagrammatically in the accompanying drawing was employed. The HB polymer was a 3-hydroxybutyrate homo-polymer, hereinafter PHB, produced by aerobic cultivation of Alcaligenes eutrophus mutant S301/C5 (NCIB 11599) on glucose. The PHB was isolated by extraction from the aqueous cell suspension with 1,2-dichloroethane at room temperature followed by separation of the solvent layer, containing the dissolved PHB, from the aqueous layer by decanting. The solution was filtered and then the PHB was precipitated by adding the solution to a methanol/water mixture. The precipitated PHB was separated by filtration, washed with methanol and dried. The dried polymer was formed into a paste with about 10% by weight of chloroform and 1% by weight of finely divided boron nitride was added as a nucleating agent. The paste was granulated by passage through a domestic mincer at room temperature. The granules were then dried in an oven to remove the chloroform and melt extruded at 190° C. and regranulated. The PHB had a weight average molecular weight of 300,000 and a melting point of 176° C.
The PHB granules were melt extruded, at a melt temperature of 185° C. at a rate of 0.28 g/min through a die (1) having a circular orifice of diameter 1.585 mm. The molten extrudate (2) was led directly into a bath (3) of water maintained at 60° C. and guided through bath (3) by guides (4, 5). The resultant solidified monofilament (6) was hauled-off at a rate of 0.026 m/sec by a haul-off roller (7) and passed round a pin (8) heated to 120° C. From the pin (8) the monofilament was drawn into a fibre (9) by a second haul-off roller (10). A plate (11) of length 20 cm maintained at 60° C. was positioned immediately below fibre (9) and between pin (8) and haul-off roller (10). From haul-off roller (10) the fibre (9) was wound up on a reel (12). Heated plate (11) thus provided a heated zone above plate (11) wherein the fibre (9) drawn from pin (8) could be further crystallised. Heated pin (8) served not only to heat the monofilament preform (6) to the drawing temperature, but also to localise the drawing position. The draw ratio was thus the ratio of the circumferential speeds of rollers (10) and (7).
By varying the positions of the guides (4, 5) in the bath (3) the length of time (hereinafter termed the quenching time) that the monofilament (6) was in the water bath (3) could be altered: in turn this varied the degree of crystallisation of the monofilament (6) at the time of drawing, i.e. at the time the fibre left pin (8). The total elapsed time from the extrudate (2) leaving die (1) to the fibre leaving pin (8) is hereinafter termed the conditioning time.
For a number of different quenching times (and hence differing conditioning times), the draw ratio was gradually increased until the fibre broke. The mechanical properties of fibres obtained at this maximum draw ratio was measured. The results are shown in the following table.
______________________________________                                    
Quench               Max.    Mechanical properties                        
Run  time     Conditioning                                                
                         draw  Tenacity                                   
                                      Extension                           
No.  (sec)    time (sec) ratio (M Pa) to Break (%)                        
______________________________________                                    
1.1  1        5          *     --     --                                  
1.2  4        8          8.0   188    30                                  
1.3  4.5      8.5        7.4   180    45                                  
1.4  5        9          7.6   196    42                                  
1.5  6        10         8.0   209    40                                  
1.6  20       24         1.1    27     8                                  
______________________________________                                    
 *The polymer was sticky and stuck to the hauloff roller 7 and pin 8      
 preventing satisfactory drawing.                                         
In our European Patent Specification No. 78609 (corresponding to U.S. Ser. No. 434,229) we described a process for the orientation of HB polymers in which the polymer preform is subjected to a compression step, e.g. cold rolling, prior to drawing. No such compression step need be employed in the process of the present invention.

Claims (8)

I claim:
1. A process for the production of an oriented shaped article from a polymer containing at least 40 mole % of 3-hydroxybutyrate residues in the polymer chain comprising uni- or bi-axially drawing a preform of said hydroxybutyrate polymer in a partially crystalline state at a temperature between the glass transition temperature, Tg, and the melting point of the hydroxybutyrate polymer into said shaped article, and then increasing the degree of crystallinity of the hydroxybutyrate polymer by subjecting the drawn preform, while in the drawn condition, to a temperature between the glass transition temperature and the drawing temperature until the drawn article is nonrubbery, the amount of said uni- or bi-axial drawing being such that, after said step of increasing the degree of crystallinity, at least one dimension of the preform has increased by at least 200%, said hydroxybutyrate polymer having a degree of crystallinity, at the time of drawing, such that the preform is not so brittle that it breaks before achieving said increase in said at least one dimension, and such that the drawn article does not break during the step of increasing the degree of crystallinity.
2. A process as claimed in claim 1 wherein the partially crystalline hydroxybutyrate polymer preform is produced by subjecting an amorphous HB polymer preform to a temperature within 30° C. of the temperature at which the rate of crystalisation of the hydroxybutyrate polymer is a maximum.
3. A process as claimed in claim 1 wherein the hydroxybutyrate polymer is melt extruded into the desired configuration to form an amorphous preform which is then passed through a quenching/crystallisation zone maintained at a temperature below the melting point of the hydroxybutyrate polymer to solidify the polymer and to effect the desired degree of crystallisation.
4. A process as claimed in claim 3 wherein the preform is fed directly from said quenching/crystallisation zone to the drawing stage.
5. A process as claimed in claim 1 wherein the drawing is conducted at a temperature above that at which the preform is partially crystallised.
6. A process as claimed in claim 1 wherein the drawing is conducted at a temperature between 30° and 80° C. below the melting point of the hydroxybutyrate polymer.
7. A process as claimed in claim 1 wherein the degree of crystallinity of the drawn preform is increased by subjecting the drawn preform to a temperature within 20° C. of the temperature at which the rate of crystallisation is a maximum.
8. A process as claimed in claim 1 wherein the drawn preform is allowed to relax, during the further crystallisation step, by up to 10% of the drawn value, of the at least one dimension that has been increased by at least 200% during the drawing step.
US06/524,314 1982-08-27 1983-08-18 Process for orienting partially crystallized 3-hydroxybutyrate polymers Expired - Lifetime US4537738A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8224683 1982-08-27
GB8224683 1982-08-27

Publications (1)

Publication Number Publication Date
US4537738A true US4537738A (en) 1985-08-27

Family

ID=10532574

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/524,314 Expired - Lifetime US4537738A (en) 1982-08-27 1983-08-18 Process for orienting partially crystallized 3-hydroxybutyrate polymers

Country Status (4)

Country Link
US (1) US4537738A (en)
EP (1) EP0104731B1 (en)
JP (1) JPS5959419A (en)
DE (1) DE3374698D1 (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826493A (en) * 1985-12-09 1989-05-02 W. R. Grace & Co.-Conn. Sheets materials of HB polymers
US5334520A (en) * 1990-05-25 1994-08-02 Center For Innovative Technology Production of poly-beta-hydroxybutyrate in transformed escherichia coli
US5484861A (en) * 1995-01-20 1996-01-16 Cheil Synthetics Inc. Biodegradable copolyester and method for preparing the same
US5518907A (en) * 1989-06-07 1996-05-21 Center For Innovative Technology Cloning and expression in Escherichia coli of the Alcaligenes eutrophus H16 poly-beta-hydroxybutyrate biosynthetic pathway
US5534616A (en) * 1993-01-13 1996-07-09 Zeneca Limited Polyhydroxyalkanoates and film formation therefrom
US6111006A (en) * 1994-12-19 2000-08-29 Monsanto Company Process for preparing films and coatings
WO2003072857A1 (en) * 2002-02-28 2003-09-04 Riken Polyhydroxyalkanoic acid fibers with high strength, fibers with high strength and high modulus of elasticity and processes for producing the same
US20030236358A1 (en) * 2000-12-21 2003-12-25 The Procter & Gamble Company Biodegradable polyhydroxyalkanoate copolymers having improved crystallization properties
US20040059047A1 (en) * 2000-12-21 2004-03-25 Autran Jean-Philippe Marie Method for making biodegradable polyhydroxyalkanoate copolymers having improved crystalization properties
US6794023B1 (en) 1999-10-28 2004-09-21 The Procter & Gamble Company Polymer products comprising soft and elastic biodegradable polyhydroxyalkanoate copolymer compositions and methods of preparing such polymer products
US6821612B1 (en) 1999-10-28 2004-11-23 The Procter & Gamble Company Methods for preparing soft and elastic biodegradable polyhydroxyalkanoate copolymer compositions and polymer products comprising such compositions
US20040234576A1 (en) * 2003-05-08 2004-11-25 Tepha, Inc., State Of Incorporation Delaware Polyhydroxyalkanoate medical textiles and fibers
US20050025809A1 (en) * 2003-07-08 2005-02-03 Tepha, Inc. Poly-4-hydroxybutyrate matrices for sustained drug delivery
US20060058470A1 (en) * 2004-08-03 2006-03-16 Tepha, Inc. Non-curling polyhydroxyalkanoate sutures
US20060177513A1 (en) * 2005-01-28 2006-08-10 Tepha, Inc. Embolization using poly-4-hydroxybutyrate particles
US20060287659A1 (en) * 2003-08-22 2006-12-21 Tepha, Inc. Polyhydroxyalkanoate nerve regeneration devices
US20080051490A1 (en) * 1999-03-25 2008-02-28 Williams Simon F Medical Devices and Applications of Polyhydroxyalkanoate Polymers
US20080061467A1 (en) * 2004-10-01 2008-03-13 Riken High-Strength Fiber of Biodegradable Aliphatic Polyester and Process for Producing the Same
US20080132602A1 (en) * 2006-12-01 2008-06-05 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US9370482B1 (en) 2011-09-09 2016-06-21 Harrison Yu Method of incorporating additives to shaped porous monocomponent biopolymer fibers during fiber orienting step
EP3112399A1 (en) * 2015-06-29 2017-01-04 SABIC Global Technologies B.V. Polyester sheet
US9555155B2 (en) 2014-12-11 2017-01-31 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10500303B2 (en) 2014-08-15 2019-12-10 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA866980B (en) * 1986-10-01 1987-03-12 Cyanamid De Argentina S.A.I.C. Method and apparatus for manufacturing structural constitutive members usable as bodies or modular strips
US5076983A (en) * 1990-07-16 1991-12-31 E. I. Du Pont De Nemours And Company Polyhydroxy acid films
DE69114140T2 (en) * 1990-09-11 1996-05-30 Du Pont HEAT SHRINKABLE FILMS CONTAINING POLYHYDROXYCARBOXYLIC ACIDS.
JP2709235B2 (en) * 1992-05-11 1998-02-04 昭和高分子株式会社 Polyester crimped fiber
JP2709234B2 (en) * 1992-05-11 1998-02-04 昭和高分子株式会社 Polyester staples
JP2709236B2 (en) * 1992-05-11 1998-02-04 昭和高分子株式会社 Polyester multifilament
JP2733184B2 (en) * 1992-05-12 1998-03-30 昭和高分子株式会社 Polyester flat yarn
CA2152677A1 (en) * 1993-01-26 1994-08-04 Gerardus Johannes Maria De Koning Poly[(r)-3-hydroxybutyrate] based polyester
GB9325952D0 (en) * 1993-12-20 1994-02-23 Zeneca Ltd Process for preparing films and coatings
EP0736563A1 (en) * 1995-04-07 1996-10-09 SAFTA S.p.A. Process for the manufacture of totally bio-decomposable films with high mechanical characteristics and relevant products and applications
GB9526165D0 (en) * 1995-12-21 1996-02-21 Zeneca Ltd Oriented polyester
JP3369421B2 (en) * 1996-12-18 2003-01-20 理化学研究所 Film composed of poly (3-hydroxybutanoic acid)
JP4562316B2 (en) * 2001-06-11 2010-10-13 株式会社カネカ Biodegradable fiber and method for producing the same
JP4622259B2 (en) * 2004-02-17 2011-02-02 東ソー株式会社 Resin composition
JP7289475B2 (en) * 2019-02-15 2023-06-12 国立大学法人東京工業大学 Method for producing biodegradable fiber
WO2020230807A1 (en) 2019-05-13 2020-11-19 三菱瓦斯化学株式会社 Aliphatic polyester copolymer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4360488A (en) * 1979-08-13 1982-11-23 Imperial Chemical Industries Limited Removal of solvent from gels of poly(hydroxybutyrate) and shaped articles formed therefrom
US4427614A (en) * 1980-04-30 1984-01-24 Imperial Chemical Industries Plc 3-Hydroxybutyric acid polymers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US434229A (en) 1890-08-12 Detachable furniture-joint
US3107172A (en) 1960-12-30 1963-10-15 Grace W R & Co Molded product containing poly-beta-hydroxybutyric acid and method of making
US3275610A (en) 1964-03-24 1966-09-27 Mobil Oil Corp Microbial synthesis of polymers
CH618455A5 (en) 1976-01-14 1980-07-31 Agroferm Ag
DE3063405D1 (en) 1979-02-21 1983-07-07 Ici Plc Microbiological process for the production of poly (beta-hydroxybutyric acid) and micro-organisms for use therein
DE3061384D1 (en) 1979-02-21 1983-01-27 Ici Plc A process for the extraction of poly-3-hydroxy-butyric acid from microbial cells
DE3070855D1 (en) * 1979-08-13 1985-08-14 Ici Plc Production of shaped articles by removal of solvent from gels of high molecular weight crystalline polymers
EP0046344B1 (en) 1980-08-19 1985-06-19 Imperial Chemical Industries Plc Fermentation process
EP0052459B1 (en) 1980-11-18 1985-12-04 Imperial Chemical Industries Plc Beta-hydroxybutyrate polymers
DE3168826D1 (en) * 1980-11-18 1985-03-21 Ici Plc Polymer blends
AU560653B2 (en) 1981-07-07 1987-04-16 Monsanto Company 3-hydroxybutyrate polymers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4360488A (en) * 1979-08-13 1982-11-23 Imperial Chemical Industries Limited Removal of solvent from gels of poly(hydroxybutyrate) and shaped articles formed therefrom
US4427614A (en) * 1980-04-30 1984-01-24 Imperial Chemical Industries Plc 3-Hydroxybutyric acid polymers

Cited By (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826493A (en) * 1985-12-09 1989-05-02 W. R. Grace & Co.-Conn. Sheets materials of HB polymers
US4880592A (en) * 1985-12-09 1989-11-14 W. R. Grace & Co.-Conn. Manufacture of polymeric products
US5518907A (en) * 1989-06-07 1996-05-21 Center For Innovative Technology Cloning and expression in Escherichia coli of the Alcaligenes eutrophus H16 poly-beta-hydroxybutyrate biosynthetic pathway
US5334520A (en) * 1990-05-25 1994-08-02 Center For Innovative Technology Production of poly-beta-hydroxybutyrate in transformed escherichia coli
US5534616A (en) * 1993-01-13 1996-07-09 Zeneca Limited Polyhydroxyalkanoates and film formation therefrom
US5578382A (en) * 1993-01-13 1996-11-26 Zeneca Limited Polyhydroxyalkanoates and film formation therefrom
US6111006A (en) * 1994-12-19 2000-08-29 Monsanto Company Process for preparing films and coatings
US5484861A (en) * 1995-01-20 1996-01-16 Cheil Synthetics Inc. Biodegradable copolyester and method for preparing the same
US20080051490A1 (en) * 1999-03-25 2008-02-28 Williams Simon F Medical Devices and Applications of Polyhydroxyalkanoate Polymers
US20080095823A1 (en) * 1999-03-25 2008-04-24 Metabolix, Inc. Medical Devices and Applications of Polyhydroxyalkanoate Polymers
US7553923B2 (en) 1999-03-25 2009-06-30 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
US6821612B1 (en) 1999-10-28 2004-11-23 The Procter & Gamble Company Methods for preparing soft and elastic biodegradable polyhydroxyalkanoate copolymer compositions and polymer products comprising such compositions
US6794023B1 (en) 1999-10-28 2004-09-21 The Procter & Gamble Company Polymer products comprising soft and elastic biodegradable polyhydroxyalkanoate copolymer compositions and methods of preparing such polymer products
US20040059047A1 (en) * 2000-12-21 2004-03-25 Autran Jean-Philippe Marie Method for making biodegradable polyhydroxyalkanoate copolymers having improved crystalization properties
US6825285B2 (en) 2000-12-21 2004-11-30 The Procter & Gamble Company Biodegradable polyhydroxyalkanoate copolymers having improved crystallization properties
US6838037B2 (en) 2000-12-21 2005-01-04 The Procter & Gamble Company Method for making biodegradable polyhydroxyalkanoate copolymers having improved crystallization properties
US20030236358A1 (en) * 2000-12-21 2003-12-25 The Procter & Gamble Company Biodegradable polyhydroxyalkanoate copolymers having improved crystallization properties
WO2003072857A1 (en) * 2002-02-28 2003-09-04 Riken Polyhydroxyalkanoic acid fibers with high strength, fibers with high strength and high modulus of elasticity and processes for producing the same
US20070138688A1 (en) * 2002-02-28 2007-06-21 Riken Polyhydroxyalkanoic acid fibers with high strength, fibers with high strength and high modulus of elasticity, and processes for producing the same
US7662325B2 (en) 2002-02-28 2010-02-16 Riken Polyhydroxyalkanoic acid fibers with high strength, fibers with high strength and high modulus of elasticity, and processes for producing the same
US20050158542A1 (en) * 2002-02-28 2005-07-21 Tadahisa Iwata Polyhydroxyalkanoic acid fibers with high strength, fibers with high strength and high modulus of elasticity and processes for producing the same
US7241495B2 (en) 2002-02-28 2007-07-10 Riken Polyhydroxyalkanoic acid fibers with high strength, fibers with high strength and high modulus of elasticity, and processes for producing the same
US10111738B2 (en) 2003-05-08 2018-10-30 Tepha, Inc. Polyhydroxyalkanoate medical textiles and fibers
US10314683B2 (en) 2003-05-08 2019-06-11 Tepha, Inc. Polyhydroxyalkanoate medical textiles and fibers
WO2004101002A3 (en) * 2003-05-08 2006-10-26 Tepha Inc Polyhydroxyalkanoate medical textiles and fibers
US9333066B2 (en) 2003-05-08 2016-05-10 Tepha, Inc. Method of making a medical textile from polyhydroxyalkanoate fibers
US9125719B2 (en) 2003-05-08 2015-09-08 Tepha, Inc. Polyhydroxyalkanoate medical textiles and fibers
US20040234576A1 (en) * 2003-05-08 2004-11-25 Tepha, Inc., State Of Incorporation Delaware Polyhydroxyalkanoate medical textiles and fibers
US8034270B2 (en) 2003-05-08 2011-10-11 Tepha, Inc. Polyhydroxyalkanoate medical textiles and fibers
US8758657B2 (en) 2003-05-08 2014-06-24 Tepha, Inc. Process of making polyhydroxyalkanoate medical textiles
US10136982B2 (en) 2003-05-08 2018-11-27 Tepha, Inc. Polyhydroxyalkanoate medical textiles and fibers
US20050025809A1 (en) * 2003-07-08 2005-02-03 Tepha, Inc. Poly-4-hydroxybutyrate matrices for sustained drug delivery
US20090209983A1 (en) * 2003-08-22 2009-08-20 Tepha, Inc. Polyhydroxyalkanoate nerve regeneration devices
US20060287659A1 (en) * 2003-08-22 2006-12-21 Tepha, Inc. Polyhydroxyalkanoate nerve regeneration devices
US7641825B2 (en) 2004-08-03 2010-01-05 Tepha, Inc. Method of making a polyhydroxyalkanoate filament
US20100093237A1 (en) * 2004-08-03 2010-04-15 Tepha, Inc. Non-curling polyhydroxyalkanoate sutures
US8084125B2 (en) 2004-08-03 2011-12-27 Tepha, Inc. Non-curling polyhydroxyalkanoate sutures
US20060058470A1 (en) * 2004-08-03 2006-03-16 Tepha, Inc. Non-curling polyhydroxyalkanoate sutures
US20080061467A1 (en) * 2004-10-01 2008-03-13 Riken High-Strength Fiber of Biodegradable Aliphatic Polyester and Process for Producing the Same
US7938999B2 (en) 2004-10-01 2011-05-10 Riken High-strength fiber of biodegradable aliphatic polyester and process for producing the same
US20060177513A1 (en) * 2005-01-28 2006-08-10 Tepha, Inc. Embolization using poly-4-hydroxybutyrate particles
US20110189475A1 (en) * 2006-12-01 2011-08-04 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US8753555B2 (en) 2006-12-01 2014-06-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US7943683B2 (en) 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US20080132602A1 (en) * 2006-12-01 2008-06-05 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US9370482B1 (en) 2011-09-09 2016-06-21 Harrison Yu Method of incorporating additives to shaped porous monocomponent biopolymer fibers during fiber orienting step
US10500303B2 (en) 2014-08-15 2019-12-10 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
US11426484B2 (en) 2014-08-15 2022-08-30 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
US11944709B2 (en) 2014-08-15 2024-04-02 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
US9555155B2 (en) 2014-12-11 2017-01-31 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10227713B2 (en) 2014-12-11 2019-03-12 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10590566B2 (en) 2014-12-11 2020-03-17 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
US11828006B2 (en) 2014-12-11 2023-11-28 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10066067B2 (en) 2015-06-29 2018-09-04 Sabic Global Technologies B.V. Polyester sheet
WO2017001145A1 (en) * 2015-06-29 2017-01-05 Sabic Global Technologies B.V. Polyester sheet
EP3112399A1 (en) * 2015-06-29 2017-01-04 SABIC Global Technologies B.V. Polyester sheet

Also Published As

Publication number Publication date
DE3374698D1 (en) 1988-01-07
JPH0263055B2 (en) 1990-12-27
JPS5959419A (en) 1984-04-05
EP0104731A3 (en) 1985-08-07
EP0104731A2 (en) 1984-04-04
EP0104731B1 (en) 1987-11-25

Similar Documents

Publication Publication Date Title
US4537738A (en) Process for orienting partially crystallized 3-hydroxybutyrate polymers
EP0078609B1 (en) 3-hydroxybutyric acid polymers
EP1266984B1 (en) Process for preparing biodegradable fibers
JPH0263054B2 (en)
US5443780A (en) Oriented films of polylactic acid and methods of producing same
Bigg Polylactide copolymers: Effect of copolymer ratio and end capping on their properties
WO1994028047A1 (en) Processing of polyesters
JP7222923B2 (en) Nonwoven fabric manufacturing method
JP4868521B2 (en) High-strength fiber of biodegradable aliphatic polyester and method for producing the same
EP1789488A1 (en) Nucleating agents for polyhydroxyalkanoates
FI108460B (en) Process for preparing a film of a polyhydroxyalkanoate polymer
WO2012133231A1 (en) Biodegradable polyester fiber having excellent thermal stability and strength, and method for producing same
US7662325B2 (en) Polyhydroxyalkanoic acid fibers with high strength, fibers with high strength and high modulus of elasticity, and processes for producing the same
US5006296A (en) Process for the preparation of fibers of stereoregular polystyrene
JP3864187B2 (en) High strength fiber of polyhydroxyalkanoic acid and process for producing the same
JP3864188B2 (en) High strength and high modulus fiber of polyhydroxyalkanoic acid and method for producing the same
JPH0263056B2 (en)
El-Salmawy et al. Preparing a core-sheath bicomponent fiber of poly (butylene terephthalate)/poly (butylene succinate-co-L-lactate)
JP3614020B2 (en) Method for producing aliphatic polyester multifilament
JPH08158158A (en) Biodegradable resin fiber and its production
JP6675612B2 (en) Method for producing biodegradable fiber
MXPA97005855A (en) Improved procedure for the production of polyes resins

Legal Events

Date Code Title Description
AS Assignment

Owner name: IMPERIAL CHEMICAL INDUSTRIES PLC MILLBANK, LONDON,

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:HOLMES, PAUL A.;REEL/FRAME:004166/0192

Effective date: 19830811

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: ZENECA LIMITED, ENGLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:IMPERIAL CHEMICAL INDUSTRIES PLC;REEL/FRAME:006965/0039

Effective date: 19931102

FPAY Fee payment

Year of fee payment: 12